ArticleCancer immunology, immunotherapy : CII2022
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Tyler C Haddad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it